Saftey And Feasiblilty of Transvenous Limb Perfusion with Normal Saline in Human Muscular Dystophy, Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers. [Recruiting patients with Limb-Girdle and Becker MD]
Assesment of magnetic resonance imaging and its potential use as an outcome measurement in Duchenne Muscular Dystrophy (DMD) patients. [Recruiting infants and children with DMD]
Funding: : NC TraCS # 50KR71104, MDA Clinical Research Training Grant, UNC Department of Neurology Broyhill Research Award
A Phase II, Double-Blind, Randomized, Three-Way Crossover, Placebo-Controlled, Pharmacodynamic Study of CK-2017357 in Patients with Generalized Myasthenia Gravis on Standard Therapy
A phase II randomized, double-blinded, controlled trial of Methotrexate versus Placebo in Myasthenia Gravis Patients who are considered steroid dependent. [Recruiting MGFA Class II-IV MG patients]
Funding: UNC Department of Neurology, University of Kansas Medical Center
Investigation of the ability of Otelixizumab to inhibit in vitro antigen-specific T cell responses from Myasthenia Gravis patients. [Recruiting MG patients with anti-AChR antibody]
Funding: GlaxoSmithKline Pharmaceuticals, Inc. MG0113510
A randomized, double-blind, placebo-controlled, cross-over, multi-center study of eculizumab in patients with generalized Myasthenia Gravis (GMG) who have moderate to severe weakness despite treatments with immunosuppressants. [Recruiting refractory MGFA Class II-IV MG patients]
